Hansen shares slump after revenue guidance rethink
This article was originally published in Clinica
Executive Summary
Robotic catheter technology specialist Hansen Medical suffered a 38% drop in its share price yesterday after a smaller amount of product placements in the second quarter forced it to reconsider its 2009 system sales guidance.